Battelle Memorial Institute

High-throughput, next-generation DNA sequencing (NGS) devices received their first regulatory clearances from FDA Nov. 19 when the agency granted de novo approvals to two nondisease-specific diagnosti

High-throughput, next-generation DNA sequencing (NGS) devices received their first regulatory clearances from FDA Nov. 19 when the agency granted de novo approvals to two nondisease-specific diagnosti

Invacare update Invacare Corp.’s sales continue to suffer under an FDA consent decree, but executives signaled progress toward getting released from the decree during the firm’s July 25 second-quart

A June 12 report seeks to spotlight the positive effect genomic sequencing has had on the economy amid increasing downward budget pressure on federal research funding. The report was compiled by the